Outsourcing in Clinical Trials South East
15-16 March 2016
- Company Details
- Products & Services
- White Papers
- Press Releases
- Regional Offices
- Contact Company
Outsourcing in Clinical Trials South East is returning to Cary, North Carolina, in March 2016 for the fifth year running.
Over the last 20 years, there has been a rise in contract research organisations (CROs) as benefits relating to finances and efficiency of outsourcing clinical trials have become widely apparent.
The 2016 event will bring together clinical-stage biotechs with local and nationwide CROs and service providers to address outsourcing challenges throughout the whole process.
High calibre speakers of CEO and founder levels from small-medium companies will attend to discuss real and key industry topics, including new techniques and how to select the right CRO.
This is a two-day event, opening with a panel discussion hosted by field experts to debate and answer all outsourcing queries.
The second day will provide the opportunity to join speaker hosted roundtable sessions and will offer a unique chance for a more focused and interactive way to solve industry challenges.
- Envigen Pharmaceuticals CEO Anil Sharma
- Scioderm president Robert Ryan
- Micell Technologies Clinical Affairs senior director Charlene Knape
- VDDI Pharmaceuticals president Stephen Porter
- Innovate Biopharmaceuticals president Jay P Madan